[Prevention and therapy of altitude sickness] | Canada Hyperbarics Skip to main content
Review Ther Umsch 1993

[Prevention and therapy of altitude sickness]

Maggiorini M — Ther Umsch, 1993

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

This review examined methods for preventing and treating altitude sickness.

What They Found

Researchers found that slow ascent (300-600m per day) or spending at least nine nights above 2500m in the last 30 days can help prevent acute mountain sickness (AMS). For pharmacological prevention, acetazolamide (250-500mg, 12-24 hours before ascent) is recommended for AMS, while nifedipine (3 x 20mg daily, starting one day before) is suggested for individuals with a history of high-altitude pulmonary edema (HAPE).

What This Means for Canadian Patients

Canadian patients planning trips to high altitudes, such as the Rocky Mountains or international destinations, can use this information to prepare for and prevent altitude sickness. The findings offer practical advice on gradual ascent and specific medications like acetazolamide or nifedipine to reduce the risk of acute mountain sickness or high-altitude pulmonary edema.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

A limitation of this summary is that the provided abstract was truncated, potentially omitting some of the review's full findings or specific details.

Was this summary helpful?

Study Details

Study Type Review
Category Systematic Reviews
Source Pubmed
PubMed ID 8378872
Year Published 1993
Journal Ther Umsch
MeSH Terms Acetazolamide; Altitude Sickness; Dexamethasone; Humans; Hyperbaric Oxygenation; Nifedipine

Cite This Study

Share

Find a Canadian Clinic

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.